AdvaMed rebranding
This article was originally published in The Gray Sheet
Executive Summary
VP-public affairs will be Porter Novelli's current VP-Consumer Group Mary Anne Hansan. She joins the trade association Nov. 30, replacing Lisa Wolfington, who left in June. At the Washington, D.C. office of the PR firm, Hansan led "consumer brand and safety communications" for the propane industry, AdvaMed notes. She has served as a media contact for the American Chemistry Council and advertising director of the American Plastics Council. Soon after her arrival, Hansan will choose a director of media relations - a spot to be vacated by Jeff Ezell Dec. 1. Ezell will focus on "brand awareness" for diagnostic member companies (1"The Gray Sheet" Nov. 8, 2004, In Brief). An exec-VP-federal government relations post - formerly occupied by Steve Ubl, who left to form his own consultancy in July - remains to be filled. AdvaMed's board convenes in Washington, D.C. Dec. 8-9...
You may also be interested in...
AdvaMed public affairs turnover
Mary Anne Hansan will return to Porter Novelli at the end of April after less than six months of directing communications for the medical device trade group. Her tenure marks the second consecutive short-term stint for an AdvaMed VP-public affairs; in July 2004, Lisa Wolfington left the association after holding the title for roughly one year (1"The Gray Sheet" Nov. 22, 2004, In Brief). Hansan's successor likely will wait to take cues from a new president, as the search continues for Pam Bailey's replacement. Prior to joining AdvaMed, Hansan was VP-consumer group at Porter Novelli...
AdvaMed’s Jeff Ezell
Media relations director is promoted to associate VP-diagnostics, effective Dec. 1, coordinating activities of AdvaMed's IVD sector, comprised of more than 50 member companies. Ezell, who joined the trade group in 2000 after a stint at Edelman PR, will work closely with AdvaMed staffers Carolyn Jones and Stephanie Mensh, attempting to help diagnostic firms realize a five-year objective to increase "brand awareness" for the industry as a whole, with an eye toward obtaining more favorable reimbursement...
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.